Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X3ER
|
|||
| Former ID |
DIB000072
|
|||
| Drug Name |
OP-145
|
|||
| Synonyms |
OP-145 CSOM; OPI-45; Endotoxin-neutralizing protein, Leiden UMC/OctoPlus; Otitis media therapy, Leiden UMC/OctoPlus/Green Cross
Click to Show/Hide
|
|||
| Drug Type |
Peptide
|
|||
| Indication | Chronic suppurative otitis media [ICD-11: AA91] | Phase 2 | [1] | |
| Otitis media [ICD-11: AA80-AB0Z; ICD-10: H66.9] | Phase 2 | [1] | ||
| Bronchitis [ICD-11: CA20; ICD-10: J40] | Discontinued in Phase 2 | [2] | ||
| Company |
Leiden University Medical Center
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov. 2020 May;19(5):311-332. | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020797) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.